These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16473886)

  • 1. Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization.
    Shen J; Yang X; Xiao WH; Hackett SF; Sato Y; Campochiaro PA
    FASEB J; 2006 Apr; 20(6):723-5. PubMed ID: 16473886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy.
    Zhao S; Huang L; Wu J; Zhang Y; Pan D; Liu X
    Mol Vis; 2009 Jun; 15():1231-42. PubMed ID: 19536308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1.
    Zhou SY; Xie ZL; Xiao O; Yang XR; Heng BC; Sato Y
    Mol Vis; 2010 Jul; 16():1389-98. PubMed ID: 20680097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.
    Wakusawa R; Abe T; Sato H; Sonoda H; Sato M; Mitsuda Y; Takakura T; Fukushima T; Onami H; Nagai N; Ishikawa Y; Nishida K; Sato Y
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3272-80. PubMed ID: 21345982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.
    Wakusawa R; Abe T; Sato H; Yoshida M; Kunikata H; Sato Y; Nishida K
    Am J Ophthalmol; 2008 Aug; 146(2):235-243. PubMed ID: 18486097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.
    Song HB; Jun HO; Kim JH; Fruttiger M; Kim JH
    Cell Calcium; 2015 Feb; 57(2):101-8. PubMed ID: 25605522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.
    Coch L; Mejias M; Berzigotti A; Garcia-Pras E; Gallego J; Bosch J; Mendez R; Fernandez M
    Hepatology; 2014 Aug; 60(2):633-47. PubMed ID: 24390792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization.
    Satofuka S; Ichihara A; Nagai N; Koto T; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Itoh H; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):422-9. PubMed ID: 17197563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An apelin receptor antagonist prevents pathological retinal angiogenesis with ischemic retinopathy in mice.
    Ishimaru Y; Shibagaki F; Yamamuro A; Yoshioka Y; Maeda S
    Sci Rep; 2017 Nov; 7(1):15062. PubMed ID: 29118394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Vasohibin-1 expression and tumor-associated macrophages on the angiogenesis in vitro and in vivo.
    Shen Z; Yan Y; Ye C; Wang B; Jiang K; Ye Y; Mustonen H; Puolakkainen P; Wang S
    Tumour Biol; 2016 Jun; 37(6):7267-76. PubMed ID: 26666821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Annexin A2 Receptor Inhibits Neovascularization via the Promotion of Krüppel-Like Transcription Factor 2.
    Guo T; Song H; Zhao Z; Qi Z; Zhao S
    Cell Physiol Biochem; 2018; 46(4):1617-1627. PubMed ID: 29694949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.
    Pe'er J; Shweiki D; Itin A; Hemo I; Gnessin H; Keshet E
    Lab Invest; 1995 Jun; 72(6):638-45. PubMed ID: 7540233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.
    Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
    Cancer Sci; 2016 May; 107(5):629-37. PubMed ID: 26893100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic role of somatostatin receptor 2 in a model of hypoxia-induced neovascularization in the retina: results from transgenic mice.
    Dal Monte M; Cammalleri M; Martini D; Casini G; Bagnoli P
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3480-9. PubMed ID: 17652715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization.
    Xie B; Shen J; Dong A; Swaim M; Hackett SF; Wyder L; Worpenberg S; Barbieri S; Campochiaro PA
    FASEB J; 2008 Aug; 22(8):2775-83. PubMed ID: 18381816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasohibin induces prolyl hydroxylase-mediated degradation of hypoxia-inducible factor-1α in human umbilical vein endothelial cells.
    Kozako T; Matsumoto N; Kuramoto Y; Sakata A; Motonagare R; Aikawa A; Imoto M; Toda A; Honda S; Shimeno H; Soeda S
    FEBS Lett; 2012 Apr; 586(7):1067-72. PubMed ID: 22569265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.
    Al-Shabrawey M; Bartoli M; El-Remessy AB; Platt DH; Matragoon S; Behzadian MA; Caldwell RW; Caldwell RB
    Am J Pathol; 2005 Aug; 167(2):599-607. PubMed ID: 16049343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril and vascular endothelial growth factor in a mouse model of retinopathy.
    Higgins RD; Yan Y; Geng Y; Sharma J; Barr SM
    Curr Eye Res; 2003 Aug; 27(2):123-9. PubMed ID: 14632165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.